Regulatory T-cells (Treg) in lymphoproliferative diseases


如何引用文章

全文:

详细

To purpose of the study was to research the level of regulatory T-lymphocytes (Treg) in lymphoproliferative diseases, and to evaluate their response to chemoradiotherapy. 71 studies of peripheral blood in patients with Hodgkin's lymphoma - HL (7), non-Hodgkin's lymphoma - nonHL (33) and chronic lymphocytic leukemia - CLL (31) were carried out. The phenotype of Treg cells was determined by flow cytometry as a CD45+CD4+CD25+CD127-. The increased levels of regulatory T-cells in lymphoproliferative diseases (HL, NHL and CLL) are detected, as well as their relative resistance to the components of chemoradiation therapy.

作者简介

E Kuzmina

A.F.Tsyb Medical Radiological Research Center - Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: kuzmina_e_g@mail.ru
канд. биол. наук, зав. лаб. клин. иммунологии МРНЦ им. А.Ф.Цыба - филиала ФГБУ НМИРЦ 249036, Russian Federation, Obninsk, ul. Koroleva, d. 4

T Mushkarina

A.F.Tsyb Medical Radiological Research Center - Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

науч. сотр. лаб. клин. иммунологии МРНЦ им. А.Ф.Цыба - филиала ФГБУ НМИРЦ 249036, Russian Federation, Obninsk, ul. Koroleva, d. 4

T Konstantinova

A.F.Tsyb Medical Radiological Research Center - Branch of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

науч. сотр. лаб. клин. иммунологии МРНЦ им. А.Ф.Цыба - филиала ФГБУ НМИРЦ 249036, Russian Federation, Obninsk, ul. Koroleva, d. 4


版权所有 © Consilium Medicum, 2016

Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
 


##common.cookie##